Flputnam Investment Management CO Eli Lilly & CO Transaction History

Flputnam Investment Management CO

$5.82 Billion
Q3 2024

A detailed history of Flputnam Investment Management CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Flputnam Investment Management CO holds 39,310 shares of LLY stock, worth $31.3 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

39,310

Previous 33,372 17.79%

Holding current value

$31.3 Million

Previous $30.2 Million 15.26%

% of portfolio

0.6%

Previous 0.57%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$772.14 - $960.02 $4.58 Million - $5.7 Million	5,938 Added 17.79%	39,310 $34.8 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $2.25 Million - $2.82 Million	3,104 Added 10.26%	33,372 $30.2 Million
Q1 2024 May 03, 2024	SELL	$592.2 - $792.28 $333,408 - $446,053	-563 Reduced 1.83%	30,268 $23.5 Million
Q4 2023 Jan 30, 2024	SELL	$525.19 - $619.13 $184,866 - $217,933	-352 Reduced 1.13%	30,831 $18 Million
Q3 2023 Nov 06, 2023	SELL	$434.7 - $599.3 $1.6 Million - $2.21 Million	-3,690 Reduced 10.58%	31,183 $16.7 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $901,401 - $1.21 Million	2,570 Added 7.96%	34,873 $16.4 Million
Q1 2023 Apr 27, 2023	SELL	$310.63 - $364.82 $748,307 - $878,851	-2,409 Reduced 6.94%	32,303 $11.1 Million
Q4 2022 Jan 31, 2023	SELL	$321.55 - $374.67 $227,978 - $265,641	-709 Reduced 2.0%	34,712 $12.7 Million
Q3 2022 Nov 07, 2022	BUY	$296.48 - $337.87 $185,892 - $211,844	627 Added 1.8%	35,421 $11.5 Million
Q2 2022 Aug 08, 2022	BUY	$278.73 - $327.27 $602,335 - $707,230	2,161 Added 6.62%	34,794 $11.3 Million
Q1 2022 Apr 28, 2022	BUY	$234.69 - $291.66 $597,755 - $742,858	2,547 Added 8.47%	32,633 $9.35 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $2.58 Million - $3.2 Million	11,461 Added 61.54%	30,086 $8.31 Million
Q3 2021 Oct 26, 2021	BUY	$221.6 - $272.71 $24,597 - $30,270	111 Added 0.6%	18,625 $4.3 Million
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $1.44 Million - $1.86 Million	7,948 Added 75.22%	18,514 $4.25 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $36,150 - $46,798	-220 Reduced 2.04%	10,566 $1.97 Million
Q4 2020 Feb 02, 2021	SELL	$130.46 - $172.63 $2.38 Million - $3.15 Million	-18,246 Reduced 62.85%	10,786 $1.82 Million
Q3 2020 Nov 03, 2020	SELL	$146.22 - $169.13 $99,137 - $114,670	-678 Reduced 2.28%	29,032 $4.3 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $404,348 - $486,629	2,964 Added 11.08%	29,710 $4.88 Million
Q1 2020 May 08, 2020	BUY	$119.05 - $147.35 $225,361 - $278,933	1,893 Added 7.62%	26,746 $3.71 Million
Q4 2019 Jan 30, 2020	SELL	$106.92 - $132.43 $925,606 - $1.15 Million	-8,657 Reduced 25.83%	24,853 $3.27 Million
Q3 2019 Nov 05, 2019	BUY	$106.79 - $116.16 $260,460 - $283,314	2,439 Added 7.85%	33,510 $3.75 Million
Q2 2019 Jul 25, 2019	BUY	$110.79 - $129.32 $848,208 - $990,073	7,656 Added 32.7%	31,071 $3.44 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $928,993 - $1.09 Million	8,346 Added 55.39%	23,415 $3.04 Million
Q4 2018 Feb 22, 2019	BUY	$105.9 - $118.64 $1.35 Million - $1.51 Million	12,734 Added 545.35%	15,069 $1.74 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $200,483 - $250,568	2,335 New	2,335 $251,000
Q2 2018 Aug 01, 2018	SELL	$75.7 - $86.88 $386,448 - $443,522	-5,105 Closed	0 $0
Q1 2018 May 01, 2018	SELL	$74.21 - $87.6 $2 Million - $2.36 Million	-26,941 Reduced 84.07%	5,105 $395,000
Q4 2017 Feb 06, 2018	BUY	$81.94 - $87.89 $481,561 - $516,529	5,877 Added 22.46%	32,046 $2.71 Million
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $2.02 Million - $2.24 Million	26,169	26,169 $2.24 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flputnam Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Flputnam Investment Management CO with notifications on news.

Account

Flputnam Investment Management CO Eli Lilly & CO Transaction History